Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies with a market capitalization of $151.25 billion, finds itself at a critical juncture as it navigates the post-pandemic ...

While companies like DeepSeek may find success in certain market segments, they face an uphill battle against this massive ...

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...

It's no secret that the US government is very nosy, and undertakes a ton of surveillance on its citizens. Due to that, there's huge demand for the best US VPNs. Using a VPN in the US encrypts your ...

Pfizer has reduced its stake in the British healthcare company Haleon PLC to 7.3% by selling £2.5 billion ($3 billion) worth of shares, according to a bookrunner for the sale. J.P. Morgan Securities ...

Pfizer is preparing to discuss the trial outcomes with worldwide health authorities, which could support potential regulatory filings. Credit: © 2024 Pfizer Inc ...

Teddy Stiga's golden goal in overtime lifted the USA to a thrilling 4-3 victory over Finland on Sunday night. The Boston College forward beat Finland goaltender Petteri Rimpinnen on a breakaway to ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Notable medicines subject to price increases include Pfizer’s COVID-19 drug Paxlovid, Bristol Myers Squibb’s CAR-T therapies Abecma and Breyanzi and a clutch of vaccines from Sanofi ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up to $220 million in milestones. Pfizer’s decision sent ...

Pfizer targets $4 billion in operational savings by 2024, improving margins and driving long-term profitability. PFE returned $7.1 billion via dividends in 9M-24, while reducing debt by $4.4 ...